253 related articles for article (PubMed ID: 9041182)
1. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB
Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman JG; Jen J; Merlo A; Baylin SB
Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Meléndez B; Mangues R; Serrano M; Pellicer A; Fernández-Piqueras J
Oncogene; 1997 Mar; 14(11):1361-70. PubMed ID: 9178896
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
8. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas.
Zhuang SM; Schippert A; Haugen-Strano A; Wiseman RW; Söderkvist P
Oncogene; 1998 Feb; 16(6):803-8. PubMed ID: 9488045
[TBL] [Abstract][Full Text] [Related]
9. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
Iravani M; Dhat R; Price CM
Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648
[TBL] [Abstract][Full Text] [Related]
11. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
12. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.
Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M
Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534
[TBL] [Abstract][Full Text] [Related]
13. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A
Cancer Res; 1995 Nov; 55(22):5168-72. PubMed ID: 7585567
[TBL] [Abstract][Full Text] [Related]
14. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
[TBL] [Abstract][Full Text] [Related]
15. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
Quesnel B
Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
[TBL] [Abstract][Full Text] [Related]
17. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
[TBL] [Abstract][Full Text] [Related]
19. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
Omura-Minamisawa M; Diccianni MB; Batova A; Chang RC; Bridgeman LJ; Yu J; Pullen J; Bowman WP; Yu AL
Clin Cancer Res; 2000 Apr; 6(4):1219-28. PubMed ID: 10778944
[TBL] [Abstract][Full Text] [Related]
20. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]